HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer's disease.

Abstract
Alzheimer's disease is a major cause of dementia in humans. The appearance of cognitive decline is linked to the overproduction of a short peptide called beta-amyloid (Abeta) in both soluble and aggregate forms. Here, we show that injecting macrophage colony-stimulating factor (M-CSF) to Swedish beta-amyloid precursor protein (APP(Swe))/PS1 transgenic mice, a well-documented model for Alzheimer's disease, on a weekly basis prior to the appearance of learning and memory deficits prevented cognitive loss. M-CSF also increased the number of microglia in the parenchyma and decreased the number of Abeta deposits. Senile plaques were smaller and less dense in the brain of M-CSF-treated mice compared to littermate controls treated with vehicle solution. Interestingly, a higher ratio of microglia internalized Abeta in the brain of M-CSF-treated animals and the phagocytosed peptides were located in the late endosomes and lysosomes. Less Abeta(40) and Abeta(42) monomers were also detected in the extracellular protein enriched fractions of M-CSF-treated transgenic mice when compared with vehicle controls. Finally, treating APP(Swe)/PS1 mice that were already demonstrating installed Abeta pathology stabilized the cognitive decline. Together these results provide compelling evidence that systemic M-CSF administration is a powerful treatment to stimulate bone marrow-derived microglia, degrade Abeta and prevent or improve the cognitive decline associated with Abeta burden in a mouse model of Alzheimer's disease.
AuthorsVincent Boissonneault, Mohammed Filali, Martine Lessard, Jane Relton, Gordon Wong, Serge Rivest
JournalBrain : a journal of neurology (Brain) Vol. 132 Issue Pt 4 Pg. 1078-92 (Apr 2009) ISSN: 1460-2156 [Electronic] England
PMID19151372 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Amyloid beta-Peptides
  • Macrophage Colony-Stimulating Factor
Topics
  • Alzheimer Disease (drug therapy, metabolism, pathology, psychology)
  • Amyloid beta-Peptides (metabolism)
  • Animals
  • Behavior, Animal (drug effects)
  • Brain (metabolism)
  • Cognition Disorders (etiology, metabolism, pathology, prevention & control)
  • Disease Models, Animal
  • Disease Progression
  • Drug Evaluation, Preclinical (methods)
  • Endosomes (metabolism)
  • Macrophage Colony-Stimulating Factor (therapeutic use)
  • Male
  • Mice
  • Mice, Transgenic
  • Microglia (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: